Tamil Nadu drug testing
Tamil Nadu Government Blames AIADMK for Drug Testing Failures Following Deadly Cough Syrup Tragedy
Oct 11, 2025 02:20 pm CST
The Tamil Nadu government has shifted responsibility to the previous AIADMK administration for significant failures in drug testing oversight revealed in a 2024 CAG report. These regulatory gaps have gained renewed attention following the deaths of 23 children linked to contaminated cough syrup manufactured by Tamil Nadu-based pharmaceutical company Sresan. The report highlighted alarming shortfalls in inspections and sample collection between 2016-2021, raising serious questions about pharmaceutical safety standards across India.
Deadly Oversight: Coldrif Cough Syrup Contains Banned Ingredients Linked to Multiple Child Deaths in India
Oct 08, 2025 02:13 pm CST
An investigation reveals that Coldrif cough syrup, linked to 19 children's deaths in Madhya Pradesh, contains ingredients banned for children under four years and dangerous levels of diethylene glycol. Despite a 2023 government directive requiring warning labels and WHO-GMP certification requirements following global child fatalities from contaminated medications, the manufacturer Sresan Pharmaceuticals continued production with 480 times the permitted toxic chemical level without proper certification.
Contaminated Cough Syrup Crisis: Tamil Nadu's Swift Action Contrasts Madhya Pradesh's Delayed Response in Child Deaths Investigation
Oct 04, 2025 02:47 pm CST
A comparative analysis of two Indian states' responses to potentially lethal contaminated cough syrup: While Tamil Nadu identified and banned Coldrif Syrup containing 48.6% Diethylene Glycol within 24 hours, Madhya Pradesh continues to delay action despite nine child fatalities showing classic signs of industrial solvent poisoning, raising serious questions about public health priorities and accountability in pharmaceutical regulation.